|Articles|October 1, 2006

Distribution Rights

AgriLabs, Ltd., was awarded exclusive distribution, sales and marketing responsibilities for the BeluMedX equine wound care product line, including the Lacerum? brand of Equine Wound Management products sold exclusively to veterinarians.

AgriLabs, Ltd., was awarded exclusive distribution, sales and marketing responsibilities for the BeluMedX equine wound care product line, including the Lacerum® brand of Equine Wound Management products sold exclusively to veterinarians.

Lacerum Equine Wound Management products are made from equine immunoglobulins and the antioxidants vitamins A, E and C in an aloe vera gel. Used in sequence, they provide a complete system for equine wound care.

For fastest response, call

(800) 542-8916 ext. 115

www.agrilabs.com

From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.

Distribution Rights

Related Content

Elanco completes $120 million expansion of its Kansas biologics plant

Q&A: How veterinarians can recognize and manage common parrot behavior problems

Two UC Davis clinical trials are recruiting dogs with glioma

New report examines pet insurance's impact on US veterinary practices

Texas couple sentenced for selling smuggled veterinary drugs and pesticides

Latest CE

Perfect Timing: protecting dogs from tick-borne infections

Strategically Planning How to Set Up Your Finances for a Banner Year

CKD: New and Old Management Options

All things allergies! From nose to tail and ear to paw..

Maximize the Value of Your Multi-DVM Practice in Today's Selling Landscape

Treating Diabetes in Dogs and Cats: How to Get Started on the Right Foot

Chronic Pain Management: Looking beyond NSAIDs

5 Ways to Build Better Patient-Client Relationships With AI: Strengthening Care and Connection in Veterinary Practice

Mastering Atopic Dermatitis: Multimodal Management for Holistic Control

Ultra-Easy Ultrasound: Handheld Diagnostic Imaging for Picture-Perfect Outcomes - Case Studies

Save More Teeth with ReGum Vet

5 Investments That Should Be Part of Every Owner's Portfolio

A comparative look at pet food formats: Making informed choices for our pets

Chat FecalGPT? Using AI for Revolutionary Parasite Diagnostics and Prevention

Safety Shows Respect: OSHA compliance as a way to boost morale and bond teams

Cobalamin Status in Patients With Chronic GI Disease and Management

Why 2+DVM Practices Are at Risk Today: Myths Guide Many Decisions...Not FACTS!

Chronic Disease Management in Practice: Enhancing Care Through Personalized Recommendations

Make or Break: How the Right Mentorship Program Can Define Your Veterinary Career

Can I help my client’s Cruciate Ligament-Deficient dog when TPLO/TTA isn’t an option?

That’s not my job!: Practical solutions for workplace toxicity

Senior Renal Care/CKD: Early Diagnosis and Slowing Progression with a Multimodal Approach

Modulating Immunity: Mushrooms, Oats, and Colostrum

Paws and Reflect: Transforming Pet Health with Nutrition for Obesity, GI, and Urinary Tract Wellness

The Heart of the Matter: Managing complex congestive heart failure

Four Tactics That Make Financial Failure Virtually Impossible

The Role of JAK Inhibitors in Treating Pruritus Associated with Allergic and Atopic Dermatitis in Canines

Creating a Calmer Clinic

Puppy Socialization or Infectious Disease Prevention – Can’t We Have Both??

From Diagnosis to Lifelong Care: Advancing Feline Chronic Kidney Disease Management

Suture Basics and Applications

Save More Teeth with ReGum Vet Podcast

A Modern Approach to Canine Atopic Dermatitis: is there a better way?

Feline Fine: The Value of Wellness Testing and Parasite Prevention in Cats

Trending on dvm360

Texas couple sentenced for selling smuggled veterinary drugs and pesticides

New report examines pet insurance's impact on US veterinary practices

The Farmer's Dog becomes NFL's first official pet food partner

Federal judge dismisses Lincoln Memorial University's antitrust lawsuit against the AVMA

Two UC Davis clinical trials are recruiting dogs with glioma